Investors ditched shares of Biogen on after an experimental Alzheimer's treatment yielded less-than-hoped-for results in stunting the disease's progression https://cbsn.ws/2LsZPhd pic.twitter.com/TXgs9edMUU
1:44 PM - 26 Jul 2018
1 reply
18 retweets
19 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.